Joel latham ihl
Web16 mrt. 2024 · Mr Joel Latham Managing Director and Chief Executive Officer +61 409 840 786 [email protected] Investor Relations Contact - United States Alyssa Factor … Web16 mrt. 2024 · “This opportunity is something the IHL team have been working towards for some time now and presents a pivotal point in the journey of the company, turning from …
Joel latham ihl
Did you know?
Web14 apr. 2024 · MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ ... Mr Joel Latham Managing Director and Chief Executive Officer +61 409 840 786 [email protected]. Investor Relations Contact – United States WebIncannex Healthcare Ltd公司简介，包括公司概况，股票信息，联系电话，及公司业务介绍。
Web22 apr. 2024 · Latham highlighted that with the results from its PIND meeting, IHL continues to build momentum for its proprietary treatments for what is a major market opportunity. … Web15 uur geleden · Melbourne, Australia, April 14, 2024 - Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) ('Incannex' or 'the Company') a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs is pleased to announce that is has appointed Quest …
Web22 jul. 2024 · extension to its phase 2b clinical trial, which will recruit people who have experienced a benefit from the sleep apnoea treatment and will assess its performance over an extended timeframe. Incannex Healthcare Chief Executive Officer and Managing Director Joel Latham said the company was delighted to receive ethics approval. Web18 mrt. 2024 · Medical cannabis company Incannex Healthcare Limited (IHL) plans a loyalty issue of options to all shareholders in Australia or New Zealand. Loyalty options will be issued based on shareholdings as of 5pm AEDT March 23, 2024, with one free option for each 15 shares held. The loyalty options will have an exercise price of 35 cents each and ...
Web14 apr. 2024 · MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) ... Mr Joel Latham Managing Director and Chief Executive Officer +61 409 840 786
WebCEO Joel Latham (32 yo) 3.7yrs Tenure AU$1,519,594 Compensation Mr. Joel Bradley Latham has been Chief Executive Officer at Incannex Healthcare Limited (also known as Impression Healthcare Ltd.) since June 29, 2024, Managing Director and Executive Director since July 2... Show more CEO Compensation Analysis delay message outlook onlineWebHealth & Biotech Incannex CEO Joel Latham tells Proactive the company has begun a Phase 2 clinical trial,... Phase 2 trial commences for treatment of rheumatoid arthritis … delay message sent outlook appWebJoel Latham holds the position of CEO, Group MD & Executive Director at Incannex Healthcare Ltd. delay minimization using taperedWeb1 apr. 2024 · Joel Latham is Chief Executive Officer, Managing Director of the company. He has worked as the General Manager of Impression for period of three years and has been instrumental in marketing and the … fenyx rising the torment of ikarosdelaymins propertyWeb17 dec. 2024 · Commenting on today’s update, CEO and managing director Joel Latham said: We are grateful to our team for their work on the registration process and now look forward to marketing the offering and listing on Nasdaq in January when institutional investors are back on deck after the relatively short winter holiday period in the northern … fenyx rising vault of aphroditeWeb10 uur geleden · MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) ... Mr Joel Latham Managing Director and Chief Executive Officer +61 409 840 786 fenyx rising vault of athena